Skip to content
RG+A
Menu
About Us
RG+A Customer Creed
Culture
Our Core Values
Senior Staff
Roger Green
Ali Spiro
Bruce Duncan, Ph.D.
Testimonials
Our Work
Our Experience
Treatment Areas and Therapeutic Drug Classes
Expert Insights
Enhancing forecast precision by simulating patient treatments
Presentation: Forecast Treatment across Multiple Therapy Lines
Doing More with Less: Utilizing Small Sample Analytics to Get the Most Out of Your Research Budget
Forecasting Physician Treatment Decisions across Multiple Lines of Therapy
Better Answers with Imprecise Data
Attribute Importance Ratings: Are We Learning Anything We Don’t Already Know?
Case Studies
Product Positioning for an Innovative In-Home Medical Device
Hazardous Drug Detection for Employee Safety
Assessing Market Potential and Development Strategy
Pricing and Volumetric Forecasting for an Orphan Drug
Using DPS®/Conjoint to Formulate a Competitive Response
Forecasting for Multiple Indications within the ADHD Market
Using Co-Creation to Support Optimal Product Profile Development and Clinical Trial Design
Applying Dynamic Practice Simulation (DPS) to Development and Commercialization Strategy
Contracting Strategy Development using Qualitative Conjoint to Segment Community Oncology Practice Managers
Forecasting and Strategy Development for a Neurological Product
Feature Optimization via Qualitative Conjoint to Combat Competitive Threat in the Vascular Device Space
Areas of Expertise
Methodologies
Iterative On-Line Qualitative Methods
Risk and Opportunity Assessment
Simulated Prescribing
News
Contact
Challenge Us
Careers
Senior Staff
RG+A Customer Creed
Culture
Our Core Values
Senior Staff
Roger Green
Founder and CEO
Ali Spiro
Vice President, Head of Research
Bruce Duncan, Ph.D.
Chief Marketing Scientist
Testimonials
Roger Green
Founder and CEO
Ali Spiro
Vice President, Head of Research
Bruce Duncan, Ph.D.
Chief Marketing Scientist
